Sonic Incytes is an FDA-approved medical device company commercializing quantitative ultrasound for non-invasive point-of-care diagnostic applications with the lead product, Liver Incytes Scan, targeting the rapidly growing fatty liver pandemic.
 

The gold standard for diagnosis and management of the fatty liver disease is magnetic resonance imaging (“MRI”) and biopsy. Sonic’s proprietary technology puts the diagnostic capabilities of MRI in the hand of every physician using standard hand-held ultrasound and artificial intelligence for measuring disease. This makes it both affordable, portable, and easy to operate, broadening access to non-invasive diagnostic imaging beyond radiology.